C. Wittermann

Antibody response following administration of two paediatric tick-borne encephalitis vaccines using two different vaccination schedules.

D. Gniel, C. Wittermann, I. Schoendorf, 2009, Vaccine.

Paediatric tick-borne encephalitis (TBE) vaccines: Schedules to optimise protection

A. Hilbert, U. Nicolay, C. Wittermann, 2008 .

Safety and Immunogenicity of the Quadrivalent Meningococcal Serogroups A, C, W and Y Tetanus Toxoid Conjugate Vaccine Coadministered With Routine Childhood Vaccines in European Infants: An Open, Randomized Trial

T. Fischbach, A. Carmona Martínez, J. M. Merino Arribas, 2017, The Pediatric infectious disease journal.

Safety, immunogenicity and tolerability of a new pediatric tick-borne encephalitis (TBE) vaccine, free of protein-derived stabilizer.

A. Hilbert, A. Banzhoff, W. Służewski, 2003, Vaccine.

Long-term Immunogenicity and Safety of the HPV-16/18 AS04-adjuvanted Vaccine in 10- to 14-year-old Girls: Open 6-year Follow-up of an Initial Observer-blinded, Randomized Trial

Tzou-Yien Lin, Li-Min Huang, T. Schwarz, 2014, The Pediatric infectious disease journal.

Five year follow-up after primary vaccination against tick-borne encephalitis in children.

A. Izu, D. Gniel, E. Fragapane, 2015, Vaccine.

Long-term persistence of tick-borne encephalitis antibodies in children 5 years after first booster vaccination with Encepur Children.

O. Zent, C. Wittermann, Eckhardt Petri, 2009, Vaccine.